Clincosm LogoSign in Get a demo

esophageal carcinoma

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation, Esophageal Carcinoma Trial in Portland (Amiodarone Hydrochloride, Saline)

Not yet recruiting
  • Atrial Fibrillation
  • Esophageal Carcinoma
  • Amiodarone Hydrochloride
  • Saline
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 28, 2023

Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)

Enrolling by invitation
  • Esophageal Carcinoma
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023

Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)

Recruiting
  • Esophageal Carcinoma
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
Aug 20, 2023

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Minimally Residual of Esophageal Cancer 001

Recruiting
  • Esophageal Carcinoma
  • Minimal Residual Disease
    • Shijiazhuang, Hebei, China
      Fourth Hospital of Hebei Medical University
    Jul 17, 2023

    Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)

    Not yet recruiting
    • Esophageal Carcinoma
    • Immune Checkpoint Inhibitors
    • (no location specified)
    Jul 6, 2023

    Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • +4 more
    • CTX131
    • Nashville, Tennessee
      Research Site 1
    Mar 21, 2023

    Nivolumab in Treatment of Early Stage Esophageal or

    Not yet recruiting
    • Esophageal Carcinoma
    • Gastroesophageal Junction Carcinoma
      • Louisville, Kentucky
      • +2 more
      Mar 21, 2023

      Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)

      Recruiting
      • Esophageal Carcinoma
      • Neoadjuvant Immunotherapy
      • PD-1 blockade
      • +2 more
      • Beijing, Beijing, China
        Qin li
      Mar 8, 2023

      Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,

      Recruiting
      • Breast Carcinoma
      • +10 more
      • Computed Tomography
      • +4 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Nov 29, 2022

      Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,

      Recruiting
      • Esophageal Carcinoma
      • +16 more
      • Educational Intervention
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 11, 2022

      Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab)

      Completed
      Has Results
      • Esophageal Carcinoma
      • Esophagogastric Junction Carcinoma
      • pembrolizumab
      • (no location specified)
      Aug 18, 2022

      ResiduAl Cancer With Liquid Biopsy Evaluation

      Recruiting
      • Bladder Carcinoma
      • +14 more
      • Guardant Reveal
      • Redwood City, California
        Redwood City
      Sep 7, 2022

      Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +49 more
      • Birmingham, Alabama
      • +1429 more
      Aug 17, 2022

      Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)

      Active, not recruiting
      • Esophageal Carcinoma
      • Rochester, New York
        University of Rochester
      Aug 17, 2022

      Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial in China (pembrolizumab, paclitaxel, docetaxel)

      Completed
      Has Results
      • Esophageal Carcinoma
      • Esophagogastric Junction Carcinoma
      • pembrolizumab
      • +3 more
      • Hefei, Anhui, China
      • +22 more
      Aug 16, 2022

      Esophageal Carcinoma Trial in Tianjin (camrelizumab)

      Recruiting
      • Esophageal Carcinoma
      • Tianjin, China
        Tianjin Medical University Cancer Institute & Hospital
      Jul 25, 2022

      Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab, paclitaxel, docetaxel)

      Completed
      Has Results
      • Esophageal Carcinoma
      • Esophagogastric Junction Carcinoma
      • pembrolizumab
      • +3 more
      • (no location specified)
      May 5, 2022

      Appendix Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Seattle (Acupuncture Therapy, Acupressure Therapy, Oral

      Recruiting
      • Appendix Carcinoma
      • +12 more
      • Acupuncture Therapy
      • +4 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Apr 11, 2022

      Esophageal Carcinoma, Neoadjuvant Chemoradiotherapy, Surgery Trial in Hangzhou (Higher dose (50.4Gy/28F) of neoadjuvant

      Recruiting
      • Esophageal Carcinoma
      • +2 more
      • Higher dose (50.4Gy/28F) of neoadjuvant chemoradiation
      • Lower dose (41.4Gy/23F) of neoadjuvant chemoradiation
      • Hangzhou, Zhejiang, China
      • +1 more
      Mar 12, 2022

      Yoga Program for Improving Quality of Life in Couples Coping

      Recruiting
      • Esophageal Carcinoma
      • +3 more
      • Best Practice
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Apr 26, 2021

      Depending on Surgical Treatment in Adenocarcinomas of

      Completed
      Has Results
      • Esophageal Carcinoma
        • (no location specified)
        Dec 9, 2020

        Esophageal Cancer, Esophageal Carcinoma, Postoperative Complications Trial in L'Hospitalet De Llobregat (Esophagectomy)

        Recruiting
        • Esophageal Cancer
        • +2 more
        • Esophagectomy
        • L'Hospitalet De Llobregat, Barcelona, Spain
          Hospital Universitari de Bellvitge
        Nov 25, 2020

        Acute and Late Normal Tissue in Patients Treated With Proton

        Recruiting
        • Breast Carcinoma
        • +8 more
        • Quality-of-Life Assessment
        • Questionnaire Administration
        • Houston, Texas
          M D Anderson Cancer Center
        Nov 11, 2020

        Bronchial Carcinoma, Esophageal Carcinoma, Tumor of the Brain Trial in Tübingen (Fitness tracker based activity training for Arm

        Recruiting
        • Bronchial Carcinoma
        • +6 more
        • Fitness tracker based activity training for Arm A and B. Booklet "physical training, exercise and cancer" and an introduction about physical activity during cancer therapy for Arm A, B, C
        • Tübingen, Baden-Württemberg, Germany
          University Hospital Tübingen
        Aug 13, 2020